The Elecsys Amyloid Plasma Panel has the potential to ensure better identification of patients that require further confirmatory testing, supporting a more timely and accessible diagnosis.
Tobacco smoke increases infant morbidity and is fatal to a baby because it damages the baby’s organs
Upgrades and global expansion provide additional control, visibility, reliability and recovery for patient-critical, time-and temperature-sensitive products
Company provides anticipated impact to second quarter 2022 financial results due to recently completed business development transactions
Younger Indians have a 10 times higher rate of heart attack
Safety in these pediatric populations was consistent with the known safety profile across approved adult and pediatric indications1,2
First and only PARP inhibitor to improve invasive disease-free survival in patients
This new €59 million, 70,000 square foot facility, officially opened today, brings 50 new jobs to the area
Acceptance based on results from the phase 3 KEYNOTE-091 trial
TAK-003 is currently undergoing regulatory review for potential licensure in both the European Union
Subscribe To Our Newsletter & Stay Updated
